Wednesday, Nov 18, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | India | Govt Issues Advisory To Regulate Stem Cell Therapy

Govt issues advisory to regulate stem cell therapy

  The government has issued an advisory tightening regulation of stem cell therapy, allowing standard clinical use only for approved indications. Stem cell treatment for autism remains limited to approved clinical trials, with unauthorised use, promotion or advertising attracting professional misconduct and disciplinary action 

By IANS
Published Date - 17 September 2026, 10:16 AM
Govt issues advisory to regulate stem cell therapy
whatsapp facebook twitter telegram

New Delhi: The government on Thursday said it has issued an advisory to regulate stem cell therapy, saying the therapy is permitted as standard care in routine clinical practice only for disease conditions or indications included in the list approved by the Health Ministry.

With regard to Autism Spectrum Disorder (ASD), the advisory stipulates that the therapeutic use of any type of stem cell in autism is to remain restricted to duly approved clinical trials, in accordance with the National Guidelines for Stem Cell Research, 2017.


The advisory, dated September 16, has been sent to all states and Union Territories that have adopted the Clinical Establishments (Registration and Regulation) Act, 2010, regarding regulation of stem cell therapy. The advisory reiterates the existing framework governing stem cell research and therapy.

The advisory also draws attention to the consequences of non-compliance with the framework governing stem cell therapy. The Supreme Court, in its judgment dated January 30, 2026, held that non-compliance with the statutory mandate must attract consequences, including professional misconduct under Regulation 7.22 of the IMC Regulations, 2002, as well as action under Sections 32 and 40 of the Clinical Establishments (Registration and Regulation) Act, 2010, which provide for cancellation of registration and penalty.

“The Ministry has accordingly requested the concerned state and District Regulatory Authorities and clinical establishments to ensure strict compliance with the applicable framework governing stem cell research and therapy,” the statement said. Moreover, the National Medical Commission (NMC), in its advisory, reiterated that stem cell therapy may be offered as standard clinical care only for the approved indications.

The advisory further states that unauthorised administration, prescription, promotion or advertisement of stem cell therapy beyond the approved indications would constitute to professional misconduct.

According to the statement, the NMC has further advised State Medical Councils to examine cases of alleged violations brought to their notice and, where professional misconduct by a Registered Medical Practitioner is established after due process, take appropriate disciplinary action in accordance with the applicable statutory and regulatory provisions.

 

 

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • clinical trials
  • Health Ministry
  • National Guidelines for Stem Cell Research
  • National Medical Commission

Related News

  • NEET-PG 2026: Plea seeks permanent copies of question papers and response sheets

    NEET-PG 2026: Plea seeks permanent copies of question papers and response sheets

  • Patient safety nodal officer is must in all medical colleges: NMC

    Patient safety nodal officer is must in all medical colleges: NMC

  • NMC rules target misleading digital marketing by doctors and private hospitals in Telangana

    NMC rules target misleading digital marketing by doctors and private hospitals in Telangana

  • No more ‘Guaranteed Cures’: NMC issues new guidelines to curb misleading medical ads on social media

    No more ‘Guaranteed Cures’: NMC issues new guidelines to curb misleading medical ads on social media

Latest News

  • Groundwater depletion raises summer water concerns in Medchal district

    3 hours ago
  • Palli Prince, M. Ramcharan score double centuries in HCA Under-19 league

    3 hours ago
  • TG- RERA imposes penalties on builders and developers for different violations

    3 hours ago
  • Cheyutha pension programme witnesses clashes across Telangana

    3 hours ago
  • Sourav Ganguly backs Rishabh Pant’s return to Delhi Capitals

    4 hours ago
  • Mahabubabad MP Balram Naik’s controversial remarks draws criticism on social media

    4 hours ago
  • Hyderabad’s SFR Snehit wins men’s singles title at National Ranking Table Tennis Championships

    4 hours ago
  • Editorial: Countering China’s dominance

    4 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App